The global U.S. Medical Foods Market is estimated to be valued at US$ 22328.51 Mn in 2023 and is expected to exhibit a CAGR of 17% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:-

Medical foods are designed to be consumed or administered enterally under the supervision of a physician to meet the distinctive nutritional requirements of a patient with disease or health-related conditions. Medical foods aim to fulfill the nutritional requirements of specific diseases and conditions, thereby enhancing dietary management for these targets.

Market key trends:-

One of the key trends fueling the growth of the U.S. medical foods market is increasing incidence and prevalence of Crohn’s disease. Crohn’s disease is a type of inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal (GI) tract from mouth to anus. As per the Crohn’s & Colitis Foundation, around 1.6 million American adults and children were living with Crohn’s disease in 2019. This is expected to significantly boost the demand for specialized medical foods in the country. Moreover, increasing awareness regarding prebiotics and probiotic products and their health benefits is also contributing to the market growth.

Segment Analysis:-

The U.S. medical foods market is segmented based on product type, form, distribution channel, application and region. Based on product type, the market is segmented into pill, powder, and others. The pill segment currently dominates the market due to the ease of administration and availability in various dosage forms such as capsules and tablets.

Key Takeaways:-

The Global U.S. Medical Foods Market Size is expected to witness high growth, exhibiting a CAGR of 17.% over the forecast period, due to increasing incidence and prevalence of Crohn’s disease and increasing awareness regarding prebiotics and probiotic products.

Regional analysis:-

The western region dominates the U.S. medical foods market with the highest market share. This is attributed to the growing burden of chronic diseases, rising geriatric population, increasing healthcare expenditure, and presence of key players in this region. The southeast region is expected to grow at the fastest pace during the forecast period.

Key players:-

Key players operating in the U.S. medical foods market are Nutricia, Baxter International Inc., Abbott, Mead Johnson & Company, LLC, Medtrition, Inc., Lonza Inc., Primus Pharmaceuticals, Inc., Nestle USA, Inc., Targeted Medical Pharma, and Accera, Inc.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it